Sulcardine Sulfate
- Generic Name
- Sulcardine Sulfate
A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)
- First Posted Date
- 2020-12-22
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- HUYABIO International, LLC.
- Target Recruit Count
- 150
- Registration Number
- NCT04680026
- Locations
- 🇺🇸
NCH Research Institute, Naples, Florida, United States
🇺🇸Prairie Education & Research, Springfield, Illinois, United States
🇺🇸North Mississippi Medical Center, Tupelo, Mississippi, United States
Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- HUYABIO International, LLC.
- Target Recruit Count
- 39
- Registration Number
- NCT04650542
- Locations
- 🇺🇸
Spaulding Clinical, West Bend, Wisconsin, United States
🇦🇺Nucleus Network Pty Ltd., Melbourne, Victoria, Australia
A Phase 1 Study of HBI-3000
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- HUYABIO International, LLC.
- Target Recruit Count
- 47
- Registration Number
- NCT03397641
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath